ES2085330T3 - Eteres ciclicos heterociclicos con actividad inhibidora de 5-lipoxigenasa. - Google Patents

Eteres ciclicos heterociclicos con actividad inhibidora de 5-lipoxigenasa.

Info

Publication number
ES2085330T3
ES2085330T3 ES90301987T ES90301987T ES2085330T3 ES 2085330 T3 ES2085330 T3 ES 2085330T3 ES 90301987 T ES90301987 T ES 90301987T ES 90301987 T ES90301987 T ES 90301987T ES 2085330 T3 ES2085330 T3 ES 2085330T3
Authority
ES
Spain
Prior art keywords
lipoxigenasa
heterociclicos
alkil
molecula
oxi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90301987T
Other languages
English (en)
Inventor
Graham Charles Crawley
Annie Hamon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca SAS
Syngenta Ltd
Original Assignee
Zeneca Pharma SA
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Pharma SA, Zeneca Ltd filed Critical Zeneca Pharma SA
Application granted granted Critical
Publication of ES2085330T3 publication Critical patent/ES2085330T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

Abstract

EL INVENTO SE REFIERE A ETERES DE LA FORMULA (I), EN LA Q ES UNA MOLECULA HETEROCICLICA BICICLICA DE DIEZ MIEMBROS O MONOCICLICA DE SEIS MIEMBROS SUSTITUIDA QUE CONTIENE UNO O DOS ATOMOS DE NITROGENO, A ES ALKILENO C1-C5, ALKENILENO C3-6, ALKINILENO C3-6, O CICLOALKILENO C3-6; X ES OXI, TIO, SULFINIL, SULFONIL O IMINO; AR FENILENO QUE PUEDE OPCIONALMENTE SOPORTAR UNO O DOS SUSTITUYENTES O AR ES UNA MOLECULA HETEROCICLICA DE SEIS MIEMBROS OPCIONALMENTE SUSTITUIDA CONTENIENDO POR ENCIMA DE TRES ATOMOS DE NITROGENO, R1 Y R2 JUNTAS FORMAN UN GRUPO DE LA FORMULA A2-X2-A3- EL CUAL JUNTO CON EL ATOMO DE OXIGENO AL CUAL A2 ESTA ENLAZADA Y CON EL ATOMO DE CARBONO AL CUAL A3 ESTA ENLAZADA DEFINE UN ANILLO QUE TIENE ENTRE 5 Y 7 ATOMOS DE ANILLO, Y EN DONDE A2 Y A3 SON CADA UNA ALKILENO C1-3 Y X2 ES OXI, TIO, SULFINIL, SULFONIL O IMINO, Y CUYO ANILLO SOPORTA 1,2 O 3 SUSTITUYENTES; R3 ES HIDROGENO, ALKIL C1-6, ALKENIL C2-C6, ALKINIL C2-6, O ALKIL C1-4 SUSTITUIDO O LAS SALES FARMACEUTICAMENTE ACEPTABLE DEL MISMO. LOS COMPUESTOS DE INVENTO SON INHIBIDORES DE LA ENZIMA 5-LIPOXIGENASA.
ES90301987T 1989-02-28 1990-02-23 Eteres ciclicos heterociclicos con actividad inhibidora de 5-lipoxigenasa. Expired - Lifetime ES2085330T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89400558 1989-02-28

Publications (1)

Publication Number Publication Date
ES2085330T3 true ES2085330T3 (es) 1996-06-01

Family

ID=8202929

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90301987T Expired - Lifetime ES2085330T3 (es) 1989-02-28 1990-02-23 Eteres ciclicos heterociclicos con actividad inhibidora de 5-lipoxigenasa.

Country Status (14)

Country Link
EP (1) EP0385679B1 (es)
JP (1) JPH02273673A (es)
AT (1) ATE137234T1 (es)
AU (1) AU626988B2 (es)
CA (1) CA2009827A1 (es)
DE (1) DE69026639T2 (es)
ES (1) ES2085330T3 (es)
FI (1) FI901010A7 (es)
GR (1) GR3019759T3 (es)
IL (1) IL93344A0 (es)
NO (1) NO174890C (es)
NZ (1) NZ232515A (es)
PT (1) PT93289A (es)
ZA (1) ZA901043B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089495A (en) * 1989-01-30 1992-02-18 Imperial Chemical Industries Plc Heterocyclic thiazole derivatives and pharmaceutical compositions comprising said derivatives
IL93343A0 (en) * 1989-02-28 1990-11-29 Ici Plc Heterocyclic cycloalkanes
IE70521B1 (en) * 1989-02-28 1996-12-11 Zeneca Pharma Sa Heterocycles with inhibitory activity of 5-lipoxygenase
IE911853A1 (en) * 1990-06-21 1992-01-01 Ici Plc Heterocyclene derivatives
IE911919A1 (en) * 1990-06-21 1992-01-01 Zeneca Ltd Bicyclic heterocyclic compounds
EP0462831B1 (en) * 1990-06-21 1996-02-28 Zeneca Limited Bicyclic pyran derivatives and their use as inhibitors of 5-lipoxygenase
IE914005A1 (en) * 1990-12-14 1992-06-17 Zeneca Ltd Novel intermediates
US5281720A (en) * 1991-02-28 1994-01-25 Merck Frosst Canada, Inc. Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis
US5227399A (en) * 1991-02-28 1993-07-13 Merck Frosst Canada, Inc. Pyranylphenyl naphthalene lactones as inhibitors of leukotriene biosynthesis
EP0540165A1 (en) * 1991-10-03 1993-05-05 Zeneca Limited Alkanoic acid derivatives
GB9300894D0 (en) * 1992-02-07 1993-03-10 Zeneca Ltd Oxime derivatives
US5308852A (en) * 1992-06-29 1994-05-03 Merck Frosst Canada, Inc. Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis
US5268379A (en) * 1992-08-24 1993-12-07 Abbott Laboratories Ether-containing inhibitors of 5-lipoxygenase
US5426109A (en) * 1992-08-27 1995-06-20 Merck Frosst Canada, Inc. Phenylnaphthalene hydroxy acids
US5252599A (en) * 1992-08-27 1993-10-12 Merck Frosst Canada, Inc. Heteroarylnaphthalene hydroxy acids as inhibitors of leukotriene biosynthesis
US5350744A (en) * 1992-08-27 1994-09-27 Merck Frosst Canada, Inc. Phenylnaphthalene lactones as inhibitors of leukotriene biosynthesis
US5428060A (en) * 1992-08-27 1995-06-27 Merck Frosst Canada, Inc. Heteroarylnaphthalene lactones as inhibitors of leukotriene biosynthesis
EP0586229A1 (en) * 1992-09-01 1994-03-09 Zeneca Limited 3-Hydroxy-3-(subst-akyl)-pyrrolidines as 5-lipoxygenase inhibitors
IL110280A0 (en) * 1993-07-27 1994-10-21 Zeneca Ltd Thiazole derivatives
EP0636624A1 (en) * 1993-07-27 1995-02-01 Zeneca Limited Thiazole derivatives as lipoxygenase inhibitors
US6825221B2 (en) 2001-10-18 2004-11-30 Allergan, Inc. Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518416A (en) * 1982-06-04 1985-05-21 Bayer Aktiengesellschaft Certain trimethyl silyl-lower-alkyl esters of pyridyloxy-phenoxy-lower alkanoic acids, compositions containing same and herbicidal method of use
US4839369A (en) * 1985-04-16 1989-06-13 Rorer Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4681940A (en) * 1985-11-19 1987-07-21 American Home Products Corporation 5-[3-[[2-quinolyl]methoxy]phenyl]-1,3-oxazoles
GB8711802D0 (en) * 1987-05-19 1987-06-24 Fujisawa Pharmaceutical Co Dithioacetal compounds

Also Published As

Publication number Publication date
CA2009827A1 (en) 1990-08-31
NZ232515A (en) 1992-03-26
NO900918D0 (no) 1990-02-27
DE69026639D1 (de) 1996-05-30
NO900918L (no) 1990-08-29
GR3019759T3 (en) 1996-07-31
NO174890C (no) 1994-07-27
EP0385679A3 (en) 1991-11-27
PT93289A (pt) 1990-08-31
ZA901043B (en) 1990-10-31
FI901010A0 (fi) 1990-02-28
EP0385679A2 (en) 1990-09-05
AU4976390A (en) 1990-09-06
ATE137234T1 (de) 1996-05-15
DE69026639T2 (de) 1996-11-14
EP0385679B1 (en) 1996-04-24
NO174890B (no) 1994-04-18
JPH02273673A (ja) 1990-11-08
IL93344A0 (en) 1990-11-29
AU626988B2 (en) 1992-08-13
FI901010A7 (fi) 1990-08-29

Similar Documents

Publication Publication Date Title
ES2085330T3 (es) Eteres ciclicos heterociclicos con actividad inhibidora de 5-lipoxigenasa.
ES2080788T3 (es) Cicloalcanos heterociclicos utiles como inhibidores de 5-lipoxigenasa.
ES2062051T3 (es) Derivados heterociclicos.
ES2080900T3 (es) Derivados piranicos utiles como inhibidores de 5-lipoxigenasa.
ES2196806T3 (es) Derivados de fenilurea y de feniltiourea.
ES2058809T3 (es) Derivados heterociclicos.
ES2079576T3 (es) Derivados piranicos biciclicos y su uso como inhibidores de 5-lipoxigenasa.
EA200200299A1 (ru) НОВЫЕ α-АМИНОКИСЛОТНЫЕ СУЛЬФОНИЛЬНЫЕ СОЕДИНЕНИЯ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ ИХ СОДЕРЖАЩИЕ
PE18095A1 (es) 3-bencilaminometil piperidinas sustituidas con heteroarilamino y heteroarilsulfonamido y compuestos afines
AR076228A1 (es) Piperidinas sustituidas como antagonistas de ccr3
AR006391A1 (es) Compuesto de 6-fenilpiridil-2-amina y composiciones farmaceuticas del mismo
AR029216A1 (es) Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento
CO5680403A2 (es) Antagonistas de mchr1r
ES2095860T3 (es) Derivados de 4-(1'-oxociclohex-2'-il)azetidin-2-ona.
CO5050295A1 (es) Activadores trans olefinicos de la glucokinasa
SE8302716D0 (sv) Bicykliska foreningar
AR012315A1 (es) Derivados de ditiolan y el uso de los mismos en la fabricacion de un medicamento.
CO4970728A1 (es) 2-aminopiridinas que contienen sustituyentes de anillos condensados
ES2055791T3 (es) Compuestos heterociclicos.
ES8605506A1 (es) Procedimiento para preparar derivados de piperidina
CO5560579A2 (es) 6,7-dihidro-5h-pirazolo[1,2-a]pirazol-1-onas espirociclicas que controlan la citosinas inflamatorias
CO4970744A1 (es) Caspasas y apoptosis
AR033942A1 (es) Compuestos de monofluoroalquilo aplicables en la potenciacion de los compuestos intermediarios utilizables en la sintesis de dichos compuestos de monofluoralquilo; composiciones farmaceuticas formuladas con dichos compuestos potenciadores y metodos para la potenciacion de las funciones de dichos rec
ES2119099T3 (es) Derivados de benzoxacina, su preparacion y su aplicacion en terapeutica.
ES2138594T3 (es) Agentes derivados de piridina e imidazol para enfermedades cardiovasculares.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 385679

Country of ref document: ES